The FDA has announced a funding opportunity for a research project titled "Development of Clinically Relevant In Vitro Performance Test for Generic OIDPs: Physiologically Relevant Models for Aerodynamic Particle Size Distribution Analysis." Two grants of $500,000 each are available. The stated goal of the project is "to investigate if realistic physical … [Read more...] about FDA announces funding opportunity for research on realistic mouth-throat models
People
3M Drug Delivery Systems names Cindy Kent President and General Manager
3M Drug Delivery Systems has announced that Cindy R. Kent has succeeded James Ingebrand as President and General Manager, effective February 2014. Ingebrand will now head 3M's dental division. Kent joined 3M in October 2013 as VP of Strategy, Business Development and US Medical Key Accounts for 3M Healthcare. She holds degrees in industrial engineering, management, … [Read more...] about 3M Drug Delivery Systems names Cindy Kent President and General Manager
Formex names Steve Massah President and CEO
CDMO Formex, formerly PharmaForm, has hired Steve Massah as President and CEO. Massah joins Formex from Gilead, where he worked in Strategic Drug Product Manufacturing and Outsourcing. He has previously held management positions with Avanir, ISTA, and Neurocrine Biosciences. Formex Chairman Masood Tayebi commented, "Steve brings a wealth of knowledge and expertise … [Read more...] about Formex names Steve Massah President and CEO
Hunein Maassab, developer of FluMist, has died
The New York Times has reported that Hunein "John" Maassab, who developed the FluMist intranasal live attenuated influenza vaccine (LAIV), died on February 1, 2014 in North Carolina. Dr. Maassab received a doctorate in epidemiology from the University of Michigan in 1956 and subsequently joined the faculty of the School of Public Health at Michigan. He retired at the … [Read more...] about Hunein Maassab, developer of FluMist, has died
Alexza hires Robert A. Lippe to head operations
Alexza Pharmaceuticals has announced the hire of Robert A. Lippe as Executive VP, Operations and Chief Operations Officer. Lippe was most recently Head of Global Operations & Operational Excellence at Ironwood Pharmaceuticals. The company is in the process of commercializing its Adasuve Staccato inhaled loxapine, which began its launch in Europe in the summer of … [Read more...] about Alexza hires Robert A. Lippe to head operations
Maurice Chagnaud to develop Lupin’s inhalation strategy
Lupin Pharmaceuticals has announced that Maurice Chagnaud has joined the company as President, Europe and Head of Inhalation Strategy. He was most recently Senior Vice President, Central & Eastern Europe at Teva. Chagnaud's responsibilities will include Lupin's European business as well as the company's "core strategy for inhalation in the developed markets." Lupin … [Read more...] about Maurice Chagnaud to develop Lupin’s inhalation strategy
Mark Iwicki named President and CEO of Civitas
Civitas Therapeutics has announced that former Sunovion CEO Mark Iwicki will succeed Glenn Batchelder as President and Chief Executive Officer. Iwicki was most recently CEO of Blend Therapeutics. According to Civitas, which is developing inhaled drugs based on its proprietary ARCUS particle manufacturing and delivery platform, Batchelder will continue to serve on the … [Read more...] about Mark Iwicki named President and CEO of Civitas
AANMA announces new CEO, headquarters
Advocacy organization Allergy & Asthma Network Mothers of Asthmatics (AANMA) has announced that Tonya Winders will take over as Chief Executive Officer as of January 1, 2014. She succeeds founder Nancy Sander, who retired in September 2013. The organization also announced that its headquarters has moved to new offices in Tysons Corner, VA. Winders, who joined AANMA … [Read more...] about AANMA announces new CEO, headquarters
Evoke Pharma adds executives as gastroparesis nasal spray moves into Phase 3
Evoke Pharma has appointed Marilyn Carlson as Chief Medical Officer and Wayne Alves as Senior Director of Clinical Operations. The company is planning to begin a Phase 3 clinical trial of EVK-001 intranasal metoclopramide for gastroparesis, which is expected to commence in the first half of 2014. Evoke President and CEO Dave Gonyer said, "Dr. Carlson and Dr. Alves … [Read more...] about Evoke Pharma adds executives as gastroparesis nasal spray moves into Phase 3
Aradigm appoints Juergen Froehlich new chief medical officer
Aradigm has announced the appointment of Juergen Froehlich as Chief Medical Officer. Froehlich is formerly Head of Regulatory Affairs at Vertex Pharmaceuticals where he was responsible for regulatory submissions for Kalydeco. Both of Aradigm's inhaled ciprofloxacin formulations, Pulmaquin and Lipoquin, were licensed by Grifols earlier this year. Aradigm … [Read more...] about Aradigm appoints Juergen Froehlich new chief medical officer